Leonard Schleifer
Co-founder and CEO of Regeneron, speaking about key products like Dupixent, eye disease therapies, oncology advances, the company's in-house discovery record, and perspectives on AI and combinations addressing cardiovascular risk.
Best podcasts with Leonard Schleifer
Ranked by the Snipd community
7 snips
Oct 30, 2025 • 19min
Regeneron CEO Dr. Leonard Schleifer on Science-Driven Success
Dr. Leonard Schleifer, co-founder and CEO of Regeneron, shares his journey from academia to leading a groundbreaking biotech company. He recounts the challenges of early fundraising and the humorous anecdotes from pitching Genentech. Discussing Regeneron's focus on science-driven research, he highlights advancements in treating allergies, oncology, and neurodegenerative diseases. Schleifer also explores the role of AI in drug development and outlines innovative plans for personalized healthcare through genomic data, emphasizing a patient-first culture.
Jan 14, 2026 • 44min
Mad Money w/ Jim Cramer 1/13/26
In this episode, Jim Cramer sits down with several industry leaders. Dr. Vass Nairosif, CEO of Novartis, shares insights on portfolio simplification and the future of radioligand therapy. Robert Bradway from Amgen discusses his company's innovative obesity drug, highlighting long-term efficacy. Dr. Leonard Schleifer of Regeneron talks about groundbreaking treatments like Dupixent and their advancements in cardiovascular risk. Jason Holler of Cardinal Health explores operational improvements and specialty distribution, emphasizing a strong financial outlook.
